InGeNA welcomes our new member Sophia Genetics Sophia Genetics Australia delivers data-driven medicine through an AI-enabled genomics platform that helps hospitals, diagnostic labs and researchers interpret genomic and radiomic data. Their cloud-native solutions...
Why Infrastructure and Industry Collaboration are Key to Australia’s Genomic Future We are living in a transformative moment for healthcare. As InGeNA CEO Dr Erin Evans recently highlighted in the Herald Sun, we are moving away from a general approach and...
Board Update We are excited to announce the appointment of two new Independent Directors. Following an extensive search and interviews with a number of highly qualified candidates InGeNA’s board are pleased to announce we have selected Monica Ferrie and Sandra...
2025’s Gene Therapy Breakthroughs Show the Future of Genomics in Action A new era of precision medicine is taking shape with remarkable speed, and few recent developments exemplify this better than the success of CRISPR-based and gene therapy interventions for rare...
InGeNA welcomes our new member VCGS VCGS (Victorian Clinical Genetics Services) are Australian experts in genetic testing. VCGS supports children, adults and families who are living with a genetic condition, or who want to understand their chance of developing one....
InGeNA welcomes our new partner CCRM InGeNA is proud to partner with CCRM Australia to strengthen the ecosystem delivering precision medicine and advanced therapies for Australians. At the heart of this partnership is a shared ambition: that every Australian has...
